Company
Date
Role
Action
Shares
Amount
Of holding
27 May 2026
CVP,Strategy/Corp Development
Sold at will
23,145
$2.00M
19.0%
15 May 2026
CVP,Strategy/Corp Development
Sold at will
9,968
$818.11K
30.4%
15 May 2026
CVP,Strategy/Corp Development
Sold at will
8,000
$654.57K
20.5%
2 Apr 2026
CVP,Strategy/Corp Development
Sold on a plan
22,680
$1.82M
51.6%
2 Mar 2026
CVP,Strategy/Corp Development
Sold on a plan
11,340
$974.43K
34.8%
25 Feb 2026
CVP,Strategy/Corp Development
Sold at will
24,000
$2.01M
53.0%
6 Jan 2026
CVP,Strategy/Corp Development
Sold on a plan
11,340
$971.43K
26.2%
12 Dec 2025
CVP,Strategy/Corp Development
Sold at will
11,386
$953.75K
22.6%
10 Dec 2025
CVP,Strategy/Corp Development
Sold on a plan
11,340
$950.58K
18.4%
2 Jun 2025
CVP,Strategy/Corp Development
Sold on a plan
2,570
$198.91K
4.9%
14 Apr 2025
CVP,Strategy/Corp Development
Sold on a plan
9,500
$663.20K
16.8%
13 Mar 2025
CVP,Strategy/Corp Development
Sold on a plan
9,500
$645.62K
16.8%
13 Feb 2025
CVP,Strategy/Corp Development
Sold on a plan
6,500
$492.36K
12.2%
16 Jan 2025
CVP,Strategy/Corp Development
Sold on a plan
5,000
$343.74K
9.6%
9 Dec 2024
CVP,Strategy/Corp Development
Sold on a plan
5,000
$358.75K
9.6%
13 Nov 2024
CVP,Strategy/Corp Development
Sold on a plan
5,000
$327.84K
9.6%
15 Oct 2024
CVP,Strategy/Corp Development
Sold on a plan
5,000
$347.53K
9.6%
11 Sep 2024
CVP,Strategy/Corp Development
Sold on a plan
5,000
$333.83K
9.6%
14 Aug 2024
CVP,Strategy/Corp Development
Sold on a plan
5,000
$330.42K
9.6%
10 Jul 2024
CVP,Strategy/Corp Development
Sold on a plan
5,000
$466.47K
9.6%
12 Jun 2024
CVP,Strategy/Corp Development
Sold on a plan
5,000
$437.70K
9.6%
10 May 2024
CVP,Strategy/Corp Development
Sold on a plan
5,000
$439.04K
9.5%
8 Apr 2024
CVP,Strategy/Corp Development
Sold on a plan
12,500
$1.15M
23.9%
13 Mar 2024
CVP,Strategy/Corp Development
Sold on a plan
14,500
$1.32M
26.9%
13 Feb 2024
CVP,Strategy/Corp Development
Sold on a plan
11,000
$944.16K
21.8%
12 Jan 2024
CVP,Strategy/Corp Development
Sold on a plan
10,000
$756.70K
20.2%
13 Dec 2023
CVP,Strategy/Corp Development
Sold on a plan
8,000
$574.88K
16.8%
13 Nov 2023
CVP,Strategy/Corp Development
Sold on a plan
6,000
$391.78K
13.2%
13 Oct 2023
CVP,Strategy/Corp Development
Sold on a plan
5,000
$349.91K
11.2%
14 Sep 2023
CVP,Strategy/Corp Development
Sold on a plan
4,500
$331.70K
10.2%
14 Aug 2023
CVP,Strategy/Corp Development
Sold on a plan
4,500
$356.85K
10.2%
14 Jul 2023
CVP,Strategy/Corp Development
Sold on a plan
3,500
$325.28K
8.1%
14 Jun 2023
CVP,Strategy/Corp Development
Sold on a plan
3,500
$314.20K
8.1%
10 May 2023
CVP,Strategy/Corp Development
Sold on a plan
2,500
$223.05K
7.0%
5 May 2023
CVP,Strategy/Corp Development
Sold at will
5,635
$499.40K
9.1%
6 Apr 2023
CVP,Strategy/Corp Development
Sold on a plan
6,725
$558.80K
9.7%
8 Mar 2023
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$517.56K
9.7%
6 Feb 2023
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$543.04K
9.7%
9 Jan 2023
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$521.19K
9.7%
12 Dec 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$499.80K
9.7%
8 Nov 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$460.39K
9.7%
10 Oct 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$571.63K
9.7%
8 Sep 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$611.57K
9.7%
9 Aug 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$706.19K
9.7%
8 Jul 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$656.36K
9.7%
13 Jun 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$605.41K
9.7%
9 May 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$663.82K
9.5%
8 Apr 2022
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.36M
16.3%
11 Mar 2022
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.17M
16.4%
11 Feb 2022
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.23M
16.4%
28 Jan 2022
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.12M
16.1%
10 Dec 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.34M
16.4%
5 Nov 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.29M
16.4%
8 Oct 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.22M
16.4%
10 Sep 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.35M
16.4%
6 Aug 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.26M
16.4%
9 Jul 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.20M
16.4%
14 Jun 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.10M
16.4%
7 May 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.02M
17.3%
9 Apr 2021
CVP,Strategy/Corp Development
Sold, plan not stated
13,077
$1.10M
21.1%
12 Mar 2021
CVP,Strategy/Corp Development
Sold, plan not stated
13,077
$1.08M
21.2%
5 Feb 2021
CVP,Strategy/Corp Development
Sold, plan not stated
13,077
$1.12M
21.2%
8 Jan 2021
CVP,Strategy/Corp Development
Sold, plan not stated
13,077
$1.18M
21.2%
11 Dec 2020
CVP,Strategy/Corp Development
Sold, plan not stated
13,074
$1.11M
21.2%
13 Nov 2020
CVP,Strategy/Corp Development
Sold, plan not stated
13,074
$1.05M
21.2%
9 Nov 2020
CVP,Strategy/Corp Development
Sold, plan not stated
227
$19.03K
36.0%
6 Nov 2020
CVP,Strategy/Corp Development
Sold, plan not stated
347
$27.07K
35.5%
9 Oct 2020
CVP,Strategy/Corp Development
Sold, plan not stated
13,074
$1.08M
21.2%
11 Sep 2020
CVP,Strategy/Corp Development
Sold, plan not stated
13,074
$1.08M
21.2%
28 Aug 2020
CVP,Strategy/Corp Development
Sold, plan not stated
7,200
$606.69K
5.5%
14 Aug 2020
CVP,Strategy/Corp Development
Sold, plan not stated
13,074
$1.03M
21.2%
6 Aug 2020
CVP,Strategy/Corp Development
Sold, plan not stated
12,000
$927.38K
9.7%
10 Jul 2020
CVP,Strategy/Corp Development
Sold, plan not stated
13,074
$882.03K
15.2%
12 Jun 2020
CVP,Strategy/Corp Development
Sold, plan not stated
13,074
$913.31K
15.2%
15 May 2020
CVP,Strategy/Corp Development
Sold, plan not stated
4,358
$937.67K
15.2%
8 May 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,372
$1.19M
19.3%
3 Apr 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$979.52K
20.5%
6 Mar 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.08M
20.6%
7 Feb 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.27M
20.6%
10 Jan 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.27M
20.6%
11 Dec 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.23M
20.6%
8 Nov 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.26M
20.6%
6 Nov 2019
CVP,Strategy/Corp Development
Sold, plan not stated
10,500
$2.46M
33.6%
4 Oct 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.20M
20.6%
6 Sep 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.21M
20.6%
9 Aug 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.16M
20.6%
29 Jul 2019
CVP,Strategy/Corp Development
Sold, plan not stated
21,000
$4.45M
50.3%
10 Jul 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.02M
20.6%
14 Jun 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$990.85K
20.6%
30 May 2019
CVP,Strategy/Corp Development
Sold, plan not stated
3,000
$508.79K
6.4%
17 May 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$939.90K
20.6%
8 May 2019
CVP,Strategy/Corp Development
Sold, plan not stated
300
$53.56K
1.5%
10 Apr 2019
CVP,Strategy/Corp Development
Sold, plan not stated
300
$56.99K
1.5%
13 Mar 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$966.52K
22.5%
13 Feb 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$977.63K
22.5%
16 Jan 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$891.17K
22.5%
12 Dec 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$907.45K
22.5%
14 Nov 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$822.91K
21.6%
10 Oct 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$811.25K
21.6%
12 Sep 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$792.88K
21.6%
31 Aug 2018
CVP,Strategy/Corp Development
Sold, plan not stated
75
$10.82K
0.4%
15 Aug 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$752.02K
21.5%
11 Jul 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$800.64K
21.5%
13 Jun 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$825.00K
21.6%
13 Jun 2018
CVP,Strategy/Corp Development
Sold, plan not stated
4,000
$612.86K
7.3%
23 May 2018
CVP,Strategy/Corp Development
Sold, plan not stated
6,000
$825.08K
23.1%
23 May 2018
CVP,Strategy/Corp Development
Sold, plan not stated
4,000
$550.06K
6.8%
9 May 2018
CVP,Strategy/Corp Development
Sold, plan not stated
10,000
$1.34M
33.6%
9 May 2018
CVP,Strategy/Corp Development
Sold, plan not stated
4,000
$535.92K
6.4%
11 Apr 2018
CVP,Strategy/Corp Development
Sold, plan not stated
10,000
$1.39M
33.6%
4 Apr 2018
CVP,Strategy/Corp Development
Sold, plan not stated
4,000
$539.12K
6.0%
29 Mar 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,300
$734.47K
21.3%
20 Feb 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,300
$713.91K
21.3%
12 Feb 2018
CVP,Strategy/Corp Development
Sold, plan not stated
3,750
$478.26K
5.3%
29 Jan 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,300
$674.35K
21.3%
28 Dec 2017
CVP,Strategy/Corp Development
Sold, plan not stated
5,300
$604.61K
21.3%
29 Nov 2017
CVP,Strategy/Corp Development
Sold, plan not stated
5,300
$617.18K
21.3%
30 Oct 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,300
$535.92K
21.3%
29 Sep 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,300
$576.97K
21.3%
29 Aug 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,300
$594.40K
21.3%
4 Aug 2017
CVP, Heart Valve Therapy
Sold, plan not stated
25,000
$2.90M
56.0%
28 Jul 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,300
$607.78K
5.9%
29 Jun 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,600
$656.03K
6.2%
8 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
9,100
$1.00M
10.6%
5 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
10,000
$1.10M
11.5%
4 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
10,000
$1.10M
11.5%
3 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
14,120
$1.55M
15.5%
2 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
10,000
$1.10M
12.2%
5 Apr 2017
CVP, Heart Valve Therapy
Sold, plan not stated
13,720
$1.28M
16.0%
6 Mar 2017
CVP, Heart Valve Therapy
Sold, plan not stated
13,720
$1.23M
17.0%
6 Feb 2017
CVP, Heart Valve Therapy
Sold, plan not stated
13,720
$1.23M
18.1%
12 Jan 2017
CVP, Heart Valve Therapy
Sold, plan not stated
13,720
$1.34M
19.4%
2 Nov 2016
CVP, Heart Valve Therapy
Sold, plan not stated
15,000
$1.35M
22.4%
2 Sep 2016
CVP, Heart Valve Therapy
Sold, plan not stated
18,000
$2.08M
27.7%
31 May 2016
CVP, Heart Valve Therapy
Sold, plan not stated
18,000
$1.78M
28.7%
24 Oct 2014
CVP, Heart Valve Therapy
Sold, plan not stated
30,000
$3.43M
59.1%
3 Oct 2014
CVP, Heart Valve Therapy
Sold, plan not stated
25,000
$2.63M
54.7%
10 Sep 2014
CVP, Heart Valve Therapy
Sold, plan not stated
25,000
$2.50M
54.7%
30 Jul 2014
CVP, Heart Valve Therapy
Sold, plan not stated
23,270
$2.14M
52.9%
27 Jun 2014
CVP, Heart Valve Therapy
Sold, plan not stated
25,000
$2.18M
54.8%
14 Apr 2014
CVP, Heart Valve Therapy
Sold, plan not stated
25,000
$2.05M
54.8%
4 Oct 2012
CVP, Heart Valve Therapy
Sold, plan not stated
11,530
$1.27M
35.4%
25 Jul 2012
CVP, Heart Valve Therapy
Sold, plan not stated
44,000
$4.62M
67.7%
14 Jun 2012
CVP, Heart Valve Therapy
Sold, plan not stated
23,000
$2.23M
52.4%
11 May 2012
CVP, Heart Valve Therapy
Sold, plan not stated
30,800
$2.61M
59.6%
7 May 2012
CVP, Heart Valve Therapy
Sold, plan not stated
24,000
$2.04M
51.9%
28 Feb 2012
CVP, Heart Valve Therapy
Sold, plan not stated
12,000
$879.24K
34.4%
24 Feb 2012
CVP, Heart Valve Therapy
Sold, plan not stated
1,500
$111.23K
6.1%
18 May 2011
CVP, Heart Valve Therapy
Sold, plan not stated
3,798
$339.01K
12.7%
12 May 2011
CVP, Heart Valve Therapy
Sold, plan not stated
20,000
$1.77M
40.0%
10 May 2011
CVP, Heart Valve Therapy
Sold, plan not stated
1,101
$96.97K
3.5%
9 May 2011
CVP, Heart Valve Therapy
Sold, plan not stated
1,101
$97.11K
3.4%
25 Feb 2011
CVP, Heart Valve Therapy
Sold, plan not stated
1,805
$155.27K
5.3%
30 Nov 2010
CVP, Heart Valve Therapy
Sold, plan not stated
7,306
$483.58K
17.1%
22 Nov 2010
CVP, Heart Valve Therapy
Sold, plan not stated
1,092
$73.16K
3.5%
13 May 2010
CVP, Heart Valve Therapy
Sold, plan not stated
12,500
$1.27M
46.3%
11 May 2010
CVP, Heart Valve Therapy
Sold, plan not stated
620
$62.04K
4.1%
10 May 2010
CVP, Heart Valve Therapy
Sold, plan not stated
563
$57.01K
3.6%
18 Nov 2009
CVP, Heart Valve Therapy
Sold, plan not stated
2,500
$202.58K
13.1%
28 May 2009
CVP, Heart Valve Therapy
Sold, plan not stated
8,000
$512.00K
32.8%
12 May 2009
CVP, Heart Valve Therapy
Sold, plan not stated
346
$21.80K
2.0%
11 May 2009
CVP, Heart Valve Therapy
Sold, plan not stated
604
$38.05K
3.4%
